Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
11.35
+0.72 (6.77%)
At close: Jul 16, 2026, 4:00 PM EDT
11.55
+0.20 (1.76%)
Pre-market: Jul 17, 2026, 8:12 AM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $454 million as of July 17, 2026. Its market cap has increased by 683.66% in one year.
Market Cap
454.00M
Enterprise Value
471.42M
1-Year Change
683.66%
Ranking
Category
Stock Price
$11.35
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $454.00M, a decrease of -17.98%. That is a compound annual growth rate of -6.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 454.00M | 766.44% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 447.29M |
| Prelude Therapeutics | 442.33M |
| Prothena Corporation | 441.34M |
| Sutro Biopharma | 430.83M |
| Puma Biotechnology | 428.06M |
| Eupraxia Pharmaceuticals | 426.44M |
| C4 Therapeutics | 420.16M |
| Abeona Therapeutics | 415.49M |